Reply to Pasqualotto

Clinical Infectious Diseases

Volumn 47, Issue 8, 2008, Pages 1110-1111

  Bicanic, Tihana ^a,c   Wood, Robin ^a   Meintjes, Graeme ^a,b   Rebe, Kevin ^a,b   Brouwer, Annemarie ^c,e   Loyse, Angela ^a,c   Bekker, Linda Gail ^a   Jaffar, Shabbar ^d   Harrison, Thomas ^a,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b GF Jooste Hospital   (South Africa)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE;

CREATININE CLEARANCE; CRYPTOCOCCAL MENINGOENCEPHALITIS; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG TOXICITY; ENCEPHALITIS; HEMOGLOBIN BLOOD LEVEL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MORTALITY; PRIORITY JOURNAL;

EID: 53349160797     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592118     Document Type: Letter

References (7)

1. Pasqualotto AC. Amphotericin B: the higher the dose, the higher the toxicity. Clin Infect Dis 2008; 47:1110 (in this issue).
2. Bicanic T, Wood R, Meintjes G, et al. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis 2008; 47:123-30.
3. Saag MS, Graybill RJ, Larsen RA, et al., for the Mycoses Study Group Cryptococcal Subproject. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000; 30:710-8.
4. Current Controlled Trials Web site. Trial ISRCTN95123928. Available at: http://www.controlled-trials.com/. Accessed 22 August 2008.
5. Bicanic T, Meintjes G, Wood R, et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 2007; 45:76-80.
6. McCarthy K, Meintjes G. Arthington-Skaggs B, et al. Guidelines for the prevention, diagnosis and management of cryptococcal meningitis and disseminated cryptococcosis in HIV-infected patients. Southern African J HIV Med 2007; 8:25-35.
7. Kambugu AD, Meya DB, Rhein J, et al. Outcomes of cryptocccal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008; 46:1694-701.